Name | Number of supported studies | Average coverage | |
---|---|---|---|
glomerular endothelial cell | 4 studies | 79% ± 7% |
Insufficient scRNA-seq data for expression of SOST at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
blood vessel | 92% | 3692.64 | 1222 / 1335 | 0% | 0 | 0 / 0 |
kidney | 85% | 1071.84 | 76 / 89 | 4% | 0.13 | 32 / 901 |
lung | 18% | 28.62 | 102 / 578 | 26% | 18.31 | 298 / 1155 |
heart | 26% | 40.47 | 223 / 861 | 0% | 0 | 0 / 0 |
esophagus | 1% | 1.30 | 14 / 1445 | 25% | 16.74 | 45 / 183 |
tonsil | 0% | 0 | 0 / 0 | 24% | 2.21 | 11 / 45 |
ovary | 2% | 0.68 | 3 / 180 | 22% | 1.26 | 94 / 430 |
uterus | 1% | 0.55 | 1 / 170 | 13% | 2.48 | 59 / 459 |
skin | 6% | 7.34 | 114 / 1809 | 3% | 0.08 | 12 / 472 |
thymus | 7% | 20.48 | 43 / 653 | 2% | 0.20 | 12 / 605 |
bladder | 0% | 0 | 0 / 21 | 8% | 9.43 | 41 / 504 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.28 | 2 / 29 |
brain | 3% | 1.67 | 69 / 2642 | 3% | 0.06 | 19 / 705 |
breast | 2% | 2.01 | 10 / 459 | 3% | 0.11 | 31 / 1118 |
spleen | 5% | 3.00 | 11 / 241 | 0% | 0 | 0 / 0 |
adipose | 4% | 6.49 | 52 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 2% | 1.16 | 5 / 328 | 1% | 0.07 | 2 / 178 |
prostate | 2% | 0.86 | 4 / 245 | 1% | 0.03 | 4 / 502 |
stomach | 1% | 0.23 | 2 / 359 | 2% | 0.05 | 5 / 286 |
intestine | 1% | 0.52 | 7 / 966 | 2% | 0.04 | 8 / 527 |
adrenal gland | 0% | 0 | 0 / 258 | 1% | 0.02 | 3 / 230 |
liver | 0% | 0 | 0 / 226 | 1% | 0.17 | 4 / 406 |
muscle | 0% | 0.17 | 2 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.05 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030279 | Biological process | negative regulation of ossification |
GO_0031333 | Biological process | negative regulation of protein-containing complex assembly |
GO_0071374 | Biological process | cellular response to parathyroid hormone stimulus |
GO_0030514 | Biological process | negative regulation of BMP signaling pathway |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0030509 | Biological process | BMP signaling pathway |
GO_0030178 | Biological process | negative regulation of Wnt signaling pathway |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0009612 | Biological process | response to mechanical stimulus |
GO_0001503 | Biological process | ossification |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0008201 | Molecular function | heparin binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0036122 | Molecular function | BMP binding |
GO_0005515 | Molecular function | protein binding |
GO_0140678 | Molecular function | molecular function inhibitor activity |
Gene name | SOST |
Protein name | Sclerostin |
Synonyms | UNQ2976/PRO7455/PRO7476 |
Description | FUNCTION: Negative regulator of bone growth that acts through inhibition of Wnt signaling and bone formation. . |
Accessions | Q9BQB4 ENST00000301691.3 [Q9BQB4-1] |